Proposed Settlement Announced in Talis Biomedical Corporation Securities Class Action Lawsuit Bleichmar Fonti & Auld LLP has proposed a settlement in the Talis Biomedical securities litigation, impacting all investors involved during the IPO period. Hearings are set for March 2025.

Proposed Settlement Announced in Talis Biomedical Corporation Securities Class Action Lawsuit #United_States #San_Francisco #securities_litigation #Talis_Biomedical #Bleichmar_Fonti